Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors
Shasqi, Inc.
Shasqi, Inc.
Institut Bergonié
Institut Bergonié
Elevation Oncology
Stanford University
BeiGene
Mundipharma Research Limited
Rain Oncology Inc
Washington University School of Medicine
NantCell, Inc.
Pfizer
Memorial Sloan Kettering Cancer Center
Children's Oncology Group
pharmaand GmbH
Hoffmann-La Roche
Genmab
City of Hope Medical Center
Ludwig Institute for Cancer Research
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of South Florida
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INSYS Therapeutics Inc